72
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Microbiota medicine: towards clinical revolution

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The human gastrointestinal tract is inhabited by the largest microbial community within the human body consisting of trillions of microbes called gut microbiota. The normal flora is the site of many physiological functions such as enhancing the host immunity, participating in the nutrient absorption and protecting the body against pathogenic microorganisms. Numerous investigations showed a bidirectional interplay between gut microbiota and many organs within the human body such as the intestines, the lungs, the brain, and the skin. Large body of evidence demonstrated, more than a decade ago, that the gut microbial alteration is a key factor in the pathogenesis of many local and systemic disorders. In this regard, a deep understanding of the mechanisms involved in the gut microbial symbiosis/dysbiosis is crucial for the clinical and health field. We review the most recent studies on the involvement of gut microbiota in the pathogenesis of many diseases. We also elaborate the different strategies used to manipulate the gut microbiota in the prevention and treatment of disorders. The future of medicine is strongly related to the quality of our microbiota. Targeting microbiota dysbiosis will be a huge challenge.

          Related collections

          Most cited references264

          • Record: found
          • Abstract: found
          • Article: not found

          Gut microbiota in human metabolic health and disease

          Observational findings achieved during the past two decades suggest that the intestinal microbiota may contribute to the metabolic health of the human host and, when aberrant, to the pathogenesis of various common metabolic disorders including obesity, type 2 diabetes, non-alcoholic liver disease, cardio-metabolic diseases and malnutrition. However, to gain a mechanistic understanding of how the gut microbiota affects host metabolism, research is moving from descriptive microbiota census analyses to cause-and-effect studies. Joint analyses of high-throughput human multi-omics data, including metagenomics and metabolomics data, together with measures of host physiology and mechanistic experiments in humans, animals and cells hold potential as initial steps in the identification of potential molecular mechanisms behind reported associations. In this Review, we discuss the current knowledge on how gut microbiota and derived microbial compounds may link to metabolism of the healthy host or to the pathogenesis of common metabolic diseases. We highlight examples of microbiota-targeted interventions aiming to optimize metabolic health, and we provide perspectives for future basic and translational investigations within the nascent and promising research field.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

            A substantial body of evidence supports that the gut microbiota plays a pivotal role in the regulation of metabolic, endocrine and immune functions. In recent years, there has been growing recognition of the involvement of the gut microbiota in the modulation of multiple neurochemical pathways through the highly interconnected gut-brain axis. Although amazing scientific breakthroughs over the last few years have expanded our knowledge on the communication between microbes and their hosts, the underpinnings of microbiota-gut-brain crosstalk remain to be determined. Short-chain fatty acids (SCFAs), the main metabolites produced in the colon by bacterial fermentation of dietary fibers and resistant starch, are speculated to play a key role in neuro-immunoendocrine regulation. However, the underlying mechanisms through which SCFAs might influence brain physiology and behavior have not been fully elucidated. In this review, we outline the current knowledge about the involvement of SCFAs in microbiota-gut-brain interactions. We also highlight how the development of future treatments for central nervous system (CNS) disorders can take advantage of the intimate and mutual interactions of the gut microbiota with the brain by exploring the role of SCFAs in the regulation of neuro-immunoendocrine function.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The human skin microbiome

              Functioning as the exterior interface of the human body with the environment, skin acts as a physical barrier to prevent the invasion of foreign pathogens while providing a home to the commensal microbiota. The harsh physical landscape of skin, particularly the desiccated, nutrient-poor, acidic environment, also contributes to the adversity that pathogens face when colonizing human skin. Despite this, the skin is colonized by a diverse microbiota. In this Review, we describe amplicon and shotgun metagenomic DNA sequencing studies that have been used to assess the taxonomic diversity of microorganisms that are associated with skin from the kingdom to the strain level. We discuss recent insights into skin microbial communities, including their composition in health and disease, the dynamics between species and interactions with the immune system, with a focus on Propionibacterium acnes, Staphylococcus epidermidis and Staphylococcus aureus.
                Bookmark

                Author and article information

                Contributors
                marvin.edeas@inserm.fr
                Journal
                J Transl Med
                J Transl Med
                Journal of Translational Medicine
                BioMed Central (London )
                1479-5876
                7 March 2022
                7 March 2022
                2022
                : 20
                : 111
                Affiliations
                [1 ]International Society of Microbiota, Tokyo, Japan
                [2 ]GRID grid.462098.1, ISNI 0000 0004 0643 431X, Department Endocrinology, Metabolism and Diabetes, Faculté de Médecine Cochin-Port Royal, , Université de Paris, INSERM U1016, Institut Cochin, ; 24 Rue du Faubourg St Jacques, 75014 Paris, France
                [3 ]GRID grid.484422.c, Laboratory of Excellence GR-Ex, ; Paris, France
                [4 ]GRID grid.467063.0, ISNI 0000 0004 0397 4222, Maternal and Child Health Department, Research Branch, , Sidra Medicine, ; Doha, Qatar
                [5 ]GRID grid.13339.3b, ISNI 0000000113287408, Medical University of Warsaw, ; Warsaw, Poland
                [6 ]GRID grid.8484.0, ISNI 0000 0004 1757 2064, University of Ferrara, ; Ferrara, Italy
                [7 ]GRID grid.17063.33, ISNI 0000 0001 2157 2938, University of Toronto, ; Toronto, Canada
                [8 ]GRID grid.21051.37, ISNI 0000 0001 0601 6589, Furtwangen University, ; Furtwangen, Germany
                [9 ]GRID grid.18147.3b, ISNI 0000000121724807, Department of Medicine and Surgery, , University of Insubria, ; Varese, Italy
                [10 ]GRID grid.22254.33, ISNI 0000 0001 2205 0971, Poznań University of Medical Sciences, ; Poznań, Poland
                [11 ]GRID grid.107950.a, ISNI 0000 0001 1411 4349, Pomeranian Medical University, ; Szczecin, Poland
                [12 ]GRID grid.4495.c, ISNI 0000 0001 1090 049X, Wroclaw Medical University, ; Wroclaw, Poland
                [13 ]GRID grid.508487.6, ISNI 0000 0004 7885 7602, Université Paris Descartes, ; Paris, France
                [14 ]GRID grid.48324.39, ISNI 0000000122482838, Clinical Research Centre, , Medical University of Bialystok, ; Bialystok, Poland
                [15 ]GRID grid.503230.7, ISNI 0000 0004 9129 4840, IRSD, Université de Toulouse, INSERM, INRAE, ENVT, UPS, ; Toulouse, France
                [16 ]GRID grid.460480.e, National Institute of Geriatrics, Rheumatology and Rehabilitation, ; Warsaw, Poland
                [17 ]GRID grid.494717.8, ISNI 0000000115480420, University of Clermont Auvergne, ; Clermont-Ferrand, France
                [18 ]GRID grid.112485.b, ISNI 0000 0001 0217 6921, Center for Molecular Biophysics CNRS UPR 4301, , University of Orléans, ; Orléans, France
                [19 ]GRID grid.9613.d, ISNI 0000 0001 1939 2794, Teaching Hospital of the University of Jena, ; Jena, Germany
                Author information
                http://orcid.org/0000-0001-7127-5229
                Article
                3296
                10.1186/s12967-022-03296-9
                8900094
                35255932
                8aabf266-67fe-4fb8-86ce-bdf82aa340a2
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 12 January 2022
                : 3 February 2022
                Categories
                Review
                Custom metadata
                © The Author(s) 2022

                Medicine
                dysbiosis,built environment microbiome,metabolites,mirnas,fecal microbiota transplant,prebiotics,probiotics,oral microbiota,metabolic syndrome

                Comments

                Comment on this article